Japan

With skin in the game, Satsuma's partner offers buyout to get migraine spray to market
With skin in the game, Satsuma's partner offers buyout to get migraine spray to market
Fierce Biotech
Satsuma Pharmaceuticals
Japan
migraines
Shin Nippon Biomedical
M&A
Flag link:
Takeda invests $760M+ into new plasma-derived therapy manufacturing site in Japan
Takeda invests $760M+ into new plasma-derived therapy manufacturing site in Japan
Endpoints
Takeda
Japan
plasma therapy
drug manufacturing
Flag link:
Japan cancels 140M dose order for Novavax Covid vaccine amid 'lower than expected' demand
Japan cancels 140M dose order for Novavax Covid vaccine amid 'lower than expected' demand
Endpoints
Japan
Novavax
COVID-19
vaccines
Takeda
Flag link:
Daiichi Sankyo to build Japan's first mRNA vaccine manufacturing facility — report
Daiichi Sankyo to build Japan's first mRNA vaccine manufacturing facility — report
Endpoints
Daiichi Sankyo
Japan
MRNA
vaccines
drug manufacturing
Flag link:
Moderna makes its first-ever acquisition, buying Japanese DNA manufacturer OriCiro for $85M
Moderna makes its first-ever acquisition, buying Japanese DNA manufacturer OriCiro for $85M
Fierce Pharma
Moderna Therapeutics
M&A
DNA
Japan
OriCiro Genomics
Flag link:
Daiichi Sankyo To Transfer Yescarta Marketing Authorization In Japan To Gilead Sciences
Daiichi Sankyo To Transfer Yescarta Marketing Authorization In Japan To Gilead Sciences
NASDAQ.com
Daiichi Sankyo
Gilead Sciences
Yescarta
Japan
Flag link:
Shionogi's COVID-19 antiviral nabs Japanese approval to rival drugs from Pfizer, Merck
Shionogi's COVID-19 antiviral nabs Japanese approval to rival drugs from Pfizer, Merck
Fierce Pharma
Shionogi
COVID-19
antivirals
Japan
Flag link:
Medtronic's Hugo Clears 3 Major Regulatory Hurdles
Medtronic's Hugo Clears 3 Major Regulatory Hurdles
Medical Devices and Diagnostics Industry
Medtronic
devices
robotic surgery
Medtech
Europe
Japan
Canada
Flag link:
Ocugen sniffs out COVID-19 vaccine opportunity, landing rights to nasal candidate with India authorization
Ocugen sniffs out COVID-19 vaccine opportunity, landing rights to nasal candidate with India authorization
Fierce Pharma
Ocugen
vaccines
COVID-19
intranasal vaccines
Europe
Japan
India
Flag link:
Daiichi Sankyo's Ezharmia Becomes First EZH1/2 Inhibitor for Blood Cancer
Daiichi Sankyo's Ezharmia Becomes First EZH1/2 Inhibitor for Blood Cancer
BioSpace
Daiichi Sankyo
Japan
Ezharmia
relapsed or refractory adult T-cell leukemia/lymphoma
Flag link:
AstraZeneca's Evusheld nabs its first global nod as a COVID treatment
AstraZeneca's Evusheld nabs its first global nod as a COVID treatment
Fierce Pharma
AstraZeneca
Evusheld
COVID-19
Japan
Flag link:
Moderna and Takeda Announce Plans to Transfer Marketing Authorization for Spikevax(TM) COVID-19 Vaccine in Japan to Moderna
Moderna and Takeda Announce Plans to Transfer Marketing Authorization for Spikevax(TM) COVID-19 Vaccine in Japan to Moderna
BioSpace
Moderna Therapeutics
Takeda
Japan
vaccines
COVID-19
Flag link:
Sanofi's Xenpozyme gets approval in Japan for rare genetic disease
Sanofi's Xenpozyme gets approval in Japan for rare genetic disease
Seeking Alpha
Sanofi
Xenpozyme
Japan
ASMD
Flag link:
Shionogi's COVID-19 vaccine matches Pfizer's Comirnaty in booster trial
Shionogi's COVID-19 vaccine matches Pfizer's Comirnaty in booster trial
Fierce Biotech
Shionogi
vaccines
COVID-19
Japan
Pfizer
Flag link:
Shionogi files for approval of oral COVID-19 antiviral in Japan, brushing off missed clinical endpoint in race to market
Shionogi files for approval of oral COVID-19 antiviral in Japan, brushing off missed clinical endpoint in race to market
Fierce Biotech
Shionogi
Japan
antivirals
COVID-19
Flag link:
Amgen Snags Another Approval for This Promising Cancer Drug
Amgen Snags Another Approval for This Promising Cancer Drug
Motley Fool
Amgen
Japan
Lumakras
non-small cell lung cancer
advanced non-small cell lung cancer
Flag link:
Daiichi makes play for share of Japan’s COVID booster market
Daiichi makes play for share of Japan’s COVID booster market
Pharmaforum
Daiichi Sankyo
COVID-19
vaccines
MRNA
Japan
DS-5670
Flag link:
Biogen, Eisai face down another Aduhelm refusal—this time from Japanese regulators
Biogen, Eisai face down another Aduhelm refusal—this time from Japanese regulators
Fierce Pharma
Biogen
Eisai
Aduhelm
Japan
Alzheimer's disease
Flag link:
Merck inks yet another $1B-plus supply deal for COVID pill, this time with Japan
Merck inks yet another $1B-plus supply deal for COVID pill, this time with Japan
Fierce Pharma
Merck
COVID-19
molnupiravir
Japan
Flag link:
Takeda bags Japanese approval for Crohn’s cell therapy Alofisel
Takeda bags Japanese approval for Crohn’s cell therapy Alofisel
Pharmaforum
Takeda
Alofisel
cell therapy
Crohn's Disease
Japan
Flag link:

Pages